Trademarkia Logo

Canada

C$
AXSOME
APPROVED

on 6 Feb 2025

Last Applicant/ Owned by

Axsome Therapeutics, Inc.

One World Trade Center, 22nd FloorNew York NY 10007

US

Serial Number

2322078 filed on 11th Jan 2024

AXSOME

Trademark usage description

medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatm Read More

Classification Information


Class [005]
Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss.


Classification kind code

12

Mark Details


Serial Number

2322078

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 18th Feb 2025
Notification of Possible Opposition Sent
Submitted for opposition 27
on 6th Feb 2025
Approval Notice Sent
Submitted for opposition 26
on 6th Feb 2025
Approved
Submitted for opposition 22
on 29th Jan 2025
Search Recorded
Submitted for opposition 257
on 18th Apr 2024
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 17th Apr 2024
Formalized
Submitted for opposition 1
on 17th Apr 2024
Created
Submitted for opposition 228
on 11th Jan 2024
International Registration
Submitted for opposition 30
on 11th Jan 2024
Filed